KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Gains from Sales and Divestitures (2016 - 2022)

Medpace Holdings has reported Gains from Sales and Divestitures over the past 6 years, most recently at $82000.0 for Q2 2022.

  • Quarterly Gains from Sales and Divestitures changed N/A to $82000.0 in Q2 2022 from the year-ago period, while the trailing twelve-month figure was $82000.0 through Jun 2022, changed N/A year-over-year, with the annual reading at $119000.0 for FY2021, N/A changed from the prior year.
  • Gains from Sales and Divestitures was $82000.0 for Q2 2022 at Medpace Holdings, roughly flat from $82000.0 in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $119000.0 in Q3 2021 and troughed at $29629.0 in Q4 2018.
  • The 3-year median for Gains from Sales and Divestitures is $82000.0 (2022), against an average of $86325.8.
  • Peak annual rise in Gains from Sales and Divestitures hit 0.0% in 2018, while the deepest fall reached 0.0% in 2018.
  • Tracing MEDP's Gains from Sales and Divestitures over 3 years: stood at $29629.0 in 2018, then surged by 301.63% to $119000.0 in 2021, then crashed by 31.09% to $82000.0 in 2022.
  • According to Business Quant data, Gains from Sales and Divestitures over the past three periods came in at $82000.0, $82000.0, and $119000.0 for Q2 2022, Q1 2022, and Q4 2021 respectively.